Alpa Laboratories Ltd vs Aurobindo Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Alpa Laboratories Ltd is ₹ 65.01 as of 30 Apr 15:30 . The P/E Ratio of Alpa Laboratories Ltd changed from 10.5 on March 2021 to 11.2 on March 2025 . This represents a CAGR of 1.30% over 5 yearsThe P/E Ratio of Aurobindo Pharma Ltd changed from 9.7 on March 2021 to 19.3 on March 2025 . This represents a CAGR of 14.75% over 5 years The Market Cap of Alpa Laboratories Ltd changed from ₹ 76.06 crore on March 2021 to ₹ 219.07 crore on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe Market Cap of Aurobindo Pharma Ltd changed from ₹ 51653 crore on March 2021 to ₹ 67951 crore on March 2025 . This represents a CAGR of 5.64% over 5 years The revenue of Alpa Laboratories Ltd for the Dec '25 is ₹ 29.96 crore as compare to the Sep '25 revenue of ₹ 29.32 crore. This represent the growth of 2.18% The revenue of Aurobindo Pharma Ltd for the Dec '25 is ₹ 8833 crore as compare to the Sep '25 revenue of ₹ 8407 crore. This represent the growth of 5.07% The ebitda of Alpa Laboratories Ltd for the Dec '25 is ₹ 2.42 crore as compare to the Sep '25 ebitda of ₹ 0.82 crore. This represent the growth of 195.12% The ebitda of Aurobindo Pharma Ltd for the Dec '25 is ₹ 1896 crore as compare to the Sep '25 ebitda of ₹ 1800 crore. This represent the growth of 5.31% The net profit of Alpa Laboratories Ltd changed from ₹ 5.1 crore to ₹ 1.9 crore over 7 quarters. This represents a CAGR of -43.12% The net profit of Aurobindo Pharma Ltd changed from ₹ 918.22 crore to ₹ 909.8 crore over 7 quarters. This represents a CAGR of -0.53% The Dividend Payout of Alpa Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Aurobindo Pharma Ltd changed from 7.53 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Alpa Laboratories Ltd

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations.
In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'.
The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh.
The unit commenced commercial production in the year 1999 of all types of formulations viz.
Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.

About Aurobindo Pharma Ltd

Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in December 1986 as a private limited company.
Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
APL is running with 29 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

FAQs for the comparison of Alpa Laboratories Ltd and Aurobindo Pharma Ltd

Which company has a larger market capitalization, Alpa Laboratories Ltd or Aurobindo Pharma Ltd?

Market cap of Alpa Laboratories Ltd is 136 Cr while Market cap of Aurobindo Pharma Ltd is 80,705 Cr

What are the key factors driving the stock performance of Alpa Laboratories Ltd and Aurobindo Pharma Ltd?

The stock performance of Alpa Laboratories Ltd and Aurobindo Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alpa Laboratories Ltd and Aurobindo Pharma Ltd?

As of May 3, 2026, the Alpa Laboratories Ltd stock price is INR ₹65.01. On the other hand, Aurobindo Pharma Ltd stock price is INR ₹1389.55.

How do dividend payouts of Alpa Laboratories Ltd and Aurobindo Pharma Ltd compare?

To compare the dividend payouts of Alpa Laboratories Ltd and Aurobindo Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.